RELAPSED PERIPHERAL T-CELL LYMPHOMA
Clinical trials for RELAPSED PERIPHERAL T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED PERIPHERAL T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED PERIPHERAL T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doctors test Cancer-Killing virus in patients who have run out of options
Disease control Recruiting nowThis early-phase study is testing a new treatment approach for patients with T-cell lymphoma that has returned or stopped responding to standard therapies. Researchers are combining a genetically modified virus designed to attack cancer cells with two immunotherapy drugs that hel…
Matched conditions: RELAPSED PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug duo tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing whether a combination of two existing drugs, pembrolizumab and olaparib, can help control a type of blood cancer called peripheral T-cell lymphoma (PTCL) in adults for whom prior treatments have stopped working. The goal is to see if this drug pair can shrin…
Matched conditions: RELAPSED PERIPHERAL T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC